
Natalie A. Lum-Tai
AssociateNatalie A. Lum-Tai
Associate
New York
+1-212-558-4000+1-212-558-4000
+1-212-558-3588+1-212-558-3588
[email protected]
Natalie Lum-Tai is an associate in the Firm’s Mergers & Acquisitions and Financial Institutions Groups. She represents clients in a range of domestic and cross-border M&A, bank regulatory, governance and financial advisory matters. Her practice covers a range of industries, including consumer & retail, healthcare, financial services and technology. Natalie also regularly advises on pro bono matters, including corporate governance, child separation, Violence Against Women Act petitions, and has acted as a special prosecutor for the Brooklyn District Attorney’s Office.
• Impax Laboratories (U.S.) in its $5.5 billion merger with Amneal Pharmaceuticals (U.S.)
• Goldman Sachs Merchant Banking (U.S.) in its acquisition of People Corporation (Canada), valuing the company at approximately 1.13 billion.
• LSC Communications (U.S.) in its acquisition by Atlas Holdings (U.S.) as part of the LSC Chapter 11 bankruptcy, 363 asset sale process
• Novartis (Switzerland) in its acquisition of The Medicines Company (U.S.), valuing the company at approximately $9.7 billion
SELECTED REPRESENTATIONS
• Andeavor (U.S.) in its $35.6 billion acquisition by Marathon Petroleum (U.S.)• Impax Laboratories (U.S.) in its $5.5 billion merger with Amneal Pharmaceuticals (U.S.)
• Goldman Sachs Merchant Banking (U.S.) in its acquisition of People Corporation (Canada), valuing the company at approximately 1.13 billion.
• LSC Communications (U.S.) in its acquisition by Atlas Holdings (U.S.) as part of the LSC Chapter 11 bankruptcy, 363 asset sale process
• Novartis (Switzerland) in its acquisition of The Medicines Company (U.S.), valuing the company at approximately $9.7 billion